Overview
Non-herpetic acute limbic encephalitis (NHALE) is a term that was historically used to describe a form of acute limbic encephalitis affecting the brain's limbic system — particularly the hippocampus, amygdala, and medial temporal lobes — that is not caused by herpes simplex virus infection. This Orphanet entry (163924) is now classified as OBSOLETE, as the condition has been reclassified and absorbed into broader and more specific diagnostic categories, most notably autoimmune encephalitis. Many cases previously labeled as non-herpetic acute limbic encephalitis are now recognized as autoimmune limbic encephalitis, often associated with specific neuronal antibodies such as anti-NMDA receptor, anti-LGI1, anti-CASPR2, anti-AMPA receptor, or anti-GABA-B receptor antibodies. Some cases are paraneoplastic, occurring in association with underlying malignancies. Patients typically presented with acute or subacute onset of confusion, memory impairment (particularly short-term memory loss), seizures, psychiatric symptoms including personality changes, hallucinations, and behavioral disturbances. MRI often showed signal abnormalities in the medial temporal lobes, and cerebrospinal fluid analysis frequently revealed inflammatory changes. The condition primarily affects the central nervous system. Because this entity has been reclassified, current clinical practice focuses on identifying the specific underlying autoimmune or paraneoplastic etiology. Treatment approaches for autoimmune limbic encephalitis include immunotherapy (corticosteroids, intravenous immunoglobulin, plasma exchange), and second-line agents such as rituximab or cyclophosphamide. When a paraneoplastic cause is identified, treatment of the underlying tumor is essential. Early diagnosis and prompt immunotherapy are associated with better neurological outcomes. Patients suspected of having this condition should be evaluated under current autoimmune encephalitis diagnostic criteria.
Variable
Can begin at different ages, from infancy through adulthood
Treatments
No FDA-approved treatments are currently listed for OBSOLETE: Non-herpetic acute limbic encephalitis.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for OBSOLETE: Non-herpetic acute limbic encephalitis at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for OBSOLETE: Non-herpetic acute limbic encephalitis.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to OBSOLETE: Non-herpetic acute limbic encephalitis.
Community
No community posts yet. Be the first to share your experience with OBSOLETE: Non-herpetic acute limbic encephalitis.
Start the conversation →Latest news about OBSOLETE: Non-herpetic acute limbic encephalitis
No recent news articles for OBSOLETE: Non-herpetic acute limbic encephalitis.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about OBSOLETE: Non-herpetic acute limbic encephalitis
What is OBSOLETE: Non-herpetic acute limbic encephalitis?
Non-herpetic acute limbic encephalitis (NHALE) is a term that was historically used to describe a form of acute limbic encephalitis affecting the brain's limbic system — particularly the hippocampus, amygdala, and medial temporal lobes — that is not caused by herpes simplex virus infection. This Orphanet entry (163924) is now classified as OBSOLETE, as the condition has been reclassified and absorbed into broader and more specific diagnostic categories, most notably autoimmune encephalitis. Many cases previously labeled as non-herpetic acute limbic encephalitis are now recognized as autoimmune